Cargando…
ATP128 Clinical Therapeutic Cancer Vaccine Activates NF-κB and IRF3 Pathways through TLR4 and TLR2 in Human Monocytes and Dendritic Cells
SIMPLE SUMMARY: Peptide-based cancer vaccines require adjuvants to increase their immunogenicity to mount an antigen-specific reliable immune response. We have previously shown that immunization with self-adjuvanting peptide-based vaccines issued from our KISIMA vaccine platform, and targeting tumor...
Autores principales: | Pascolutti, Roberta, Yeturu, Lakshmi, Philippin, Géraldine, Costa Borges, Stéphane, Dejob, Magali, Santiago-Raber, Marie-Laure, Derouazi, Madiha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600632/ https://www.ncbi.nlm.nih.gov/pubmed/36291919 http://dx.doi.org/10.3390/cancers14205134 |
Ejemplares similares
-
IRF7 Regulates TLR2-Mediated Activation of Splenic CD11c(hi) Dendritic Cells
por: Owens, Benjamin M. J., et al.
Publicado: (2012) -
Swine IRF3/IRF7 attenuates inflammatory responses through TLR4 signaling pathway
por: Chen, Pei-Ge, et al.
Publicado: (2017) -
CXCL4 synergizes with TLR8 for TBK1-IRF5 activation, epigenomic remodeling and inflammatory response in human monocytes
por: Yang, Chao, et al.
Publicado: (2022) -
Epigenomics of conventional type-I dendritic cells depicted preferential control of TLR9 versus TLR3 response by NCoR1 through differential IRF3 activation
por: Mishra, Gyan Prakash, et al.
Publicado: (2022) -
Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists
por: Lacerte, Patricia, et al.
Publicado: (2016)